top of page

Dry Mouth

Providers

Xerostomia, the subjective complaint of dry mouth, and hyposalivation remain a significant burden for many individuals. Diagnosis of xerostomia and salivary gland hypofunction is dependent upon a careful and detailed history and thorough oral examination. There exist many options for treatment and symptom management: salivary stimulants, topical agents, saliva substitutes, and systemic sialogogues.

dry-mouth.png

Chronic xerostomia remains a significant burden for many individuals. In particular, it may affect speech, chewing, swallowing, denture-wearing, and general well-being.


Xerostomia secondary to hyposalivation may also result in rampant dental caries, oral fungal infections (e.g., candidiasis), taste changes, halitosis, or burning mouth. The most frequent cause of hyposalivation is the use of certain medications (such as anticoagulants, antidepressants, antihypertensives, antiretrovirals, hypoglycemics, levothyroxine, multivitamins and supplements, non-steroidal anti-inflammatory drugs, and steroid inhalers) followed by radiotherapy to the head and neck, and Sjögren’s syndrome. Other factors include depression, anxiety and stress, or malnutrition.” (Villa,2015)

​

​

For more information to help guide healthcare providers in the treatment of xerostomia and hyposalivation, see these resources: 

​

​​

You may also wish to learn about:

​​

​

More information regarding the following topics will be coming soon:

​

  • Importance of Good Oral Health Before, During, and After Cancer Care

  • Dental Care and Home Care Before, During, and After Treatment

​​

Image reference: Dry tongue in Sjogren's syndrome. Photography. Britannica ImageQuest, Encyclopædia Britannica, 25 May 2016.quest-eb-com.ccriezp.idm.oclc.org/search/132_1268119/1/132_1268119/cite. Accessed 25 Sep 2021.
 

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE 

The information on the Rhode Island Cancer and Oral Health Resource Guide, including but not limited to, text, graphics, images, and other external materials are for informational purposes only. The Partnership to Reduce Cancer in Rhode Island does not provide medical advice. The information on this website is not intended as a substitute for professional medical advice, diagnosis, or treatment. 

Partnership to Reduce Cancer in Rhode Island


     405 Promenade St, Ste. C
     Providence, RI 02908
     

     (401) 443-2375
 

     contact@prcri.org

Like us on Facebook

Follow us on LinkedIn

  • Instagram
  • Facebook
  • LinkedIn

The Partnership to Reduce Cancer in Rhode Island, 2024. The Partnership to Reduce Cancer in Rhode Island is a qualified 501(c)(3) tax-exempt organization. Tax ID Number: 85-2361783

​

The Partnership to Reduce Cancer in Rhode Island does not support or endorse any commercial providers of materials or services, and therefore does not accept advertising for or links to such providers on this website.

​

This program is supported in part by Cooperative Agreement Number NU58DP007118, funded by the Centers for Disease Control and Prevention and awarded to the Rhode Island Department of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, or the Rhode Island Department of Health.

bottom of page